+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Immunosuppressant Drugs Market 2019-2028

  • ID: 5134161
  • Report
  • July 2020
  • Region: Global
  • 178 pages
  • Triton Market Research

FEATURED COMPANIES

  • Abbvie Inc
  • Astellas Pharma Inc
  • Cipla Ltd
  • F Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Mylan Nv
  • MORE

MARKET OUTLOOK

According to the publisher, the global immunosuppressant drugs market is expected to display a positive market trend over the forecast period of 2019-2028, exhibiting a CAGR of 4.00%.
The growing demand for organ transplantation and the rise in the number of autoimmune disorders are the primary factors fueling the growth of this market. A malfunctioning of the immune system results in it attacking the healthy cells, tissues, and organs. Thus, immunosuppressants are used in this case to weaken the immune system. Furthermore, there is a huge demand for these drugs from growing countries. Also, the exports of drugs and medicine around the world are on the rise.

However, immunosuppressant drugs cause side-effects, which is negatively affecting their demand. This is a major restraining factor for market growth. Besides, the lack of awareness about organ donation is creating hurdles in the path of market growth.

REGIONAL OUTLOOK

The global market for immunosuppressant drugs covers the regions of North America, Latin America, the Asia-Pacific, Europe, and the Middle East and Africa.
Latin America is expected to be the fastest-growing region in the global market over the forecast period. Its pharmaceutical industry is thriving. Brazil has been dominating the region in the last few decades, which is attributable to its large population; however, Mexico is expected to surpass the country soon. The other major markets in the region are Argentina, Columbia, and Venezuela. With the booming populations, an increase in healthcare spending, and double-digit market growth, the markets in Latin America are proving to be attractive and rewarding for the global pharma industry. A growth in this industry implies a growth in the demand for immunosuppressant drugs as well. This is fueling the regional market’s growth.

COMPETITIVE OUTLOOK

The eminent companies in this market are Bristol-Myers Squibb Company, GlaxoSmithKline plc, F Hoffmann-La Roche Ltd, Pfizer Inc, Mylan NV, Dr Reddys Laboratories Ltd, Abbvie Inc, Astellas Pharma Inc, Cipla Ltd, Veloxis Pharmaceuticals Inc, Allergan (acquired by Abbvie Inc), Sanofi, Intas Pharmaceuticals Ltd (Accord Healthcare), Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc), and Novartis AG.
GlaxoSmithKline is a global leader in the field of pharmaceutical and consumer health-related products. It primarily operates in North America, Europe, and the Asia-Pacific. It has an employee strength of over 100000 people. Benlysta (belimumab) is an immunosuppressive drug offered by the company. GSK is among the world’s most prominent prescription pharmaceutical companies, and enjoys major benefits due to its global footprint.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbvie Inc
  • Astellas Pharma Inc
  • Cipla Ltd
  • F Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Mylan Nv
  • MORE
1. Global Immunosuppressant Drugs Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Key Insights
2.2.1. Organ Transplantation Leads the Market by End-User
2.2.2. Pharmaceutical Industry Showing Growth Trends
2.2.3. Impact of Covid 19 on Transplant Recipients
2.3. Evolution & Transition of Immunosuppressant Drugs
2.4. Porter's Five Force Analysis
2.4.1. Threat of New Entrants
2.4.2. Threat of Substitute
2.4.3. Bargaining Power of Suppliers
2.4.4. Bargaining Power of Buyers
2.4.5. Threat of Competitive Rivalry
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Market Drivers
2.7.1. Demand from Organ Transplantation
2.7.2. Rise in the Number of Autoimmune Disorders
2.8. Market Restraints
2.8.1. Side Effects of Immunosuppressant Drugs
2.9. Market Opportunities
2.9.1. Demand from Emerging Economies
2.9.2. Exports of Drugs and Medicine Worldwide on Rise
2.10. Market Challenges
2.10.1. Lack of Awareness About Organ Donation

3. Global Immunosuppressant Drugs Market Outlook – by Drug Class
3.1. Corticosteroids
3.2. Monoclonal Antibodies
3.3. Calcineurin Inhibitors
3.4. Mtor Inhibitors
3.5. Others

4. Global Immunosuppressant Drugs Market Outlook - by Distribution Channel
4.1. Hospital Pharmacies
4.2. Retail Pharmacies
4.3. Online Pharmacies

5. Global Immunosuppressant Drugs Market Outlook - by End-User
5.1. Organ Transplantation
5.2. Autoimmune Disorders
5.3. Others

6. Global Immunosuppressant Drugs Market – Regional Outlook
6.1. North America
6.1.1. Market by Drug Class
6.1.2. Market by Distribution Channel
6.1.3. Market by End-User
6.1.4. Country Analysis
6.1.4.1. United States
6.1.4.2. Canada
6.2. Europe
6.2.1. Market by Drug Class
6.2.2. Market by Distribution Channel
6.2.3. Market by End-User
6.2.4. Country Analysis
6.2.4.1. United Kingdom
6.2.4.2. Germany
6.2.4.3. France
6.2.4.4. Spain
6.2.4.5. Italy
6.2.4.6. Russia
6.2.4.7. Rest of Europe
6.3. Asia-Pacific
6.3.1. Market by Drug Class
6.3.2. Market by Distribution Channel
6.3.3. Market by End-User
6.3.4. Country Analysis
6.3.4.1. China
6.3.4.2. Japan
6.3.4.3. India
6.3.4.4. South Korea
6.3.4.5. Asean Countries
6.3.4.6. Australia & New Zealand
6.3.4.7. Rest of Asia-Pacific
6.4. Latin America
6.4.1. Market by Drug Class
6.4.2. Market by Distribution Channel
6.4.3. Market by End-User
6.4.4. Country Analysis
6.4.4.1. Brazil
6.4.4.2. Mexico
6.4.4.3. Rest of Latin America
6.5. Middle East and Africa
6.5.1. Market by Drug Class
6.5.2. Market by Distribution Channel
6.5.3. Market by End-User
6.5.4. Country Analysis
6.5.4.1. United Arab Emirates
6.5.4.2. Turkey
6.5.4.3. Saudi Arabia
6.5.4.4. South Africa
6.5.4.5. Rest of Middle East & Africa

7. Competitive Landscape
7.1. Abbvie Inc
7.2. Allergan (Acquired by Abbvie Inc)
7.3. Astellas Pharma Inc
7.4. Bristol-Myers Squibb Company
7.5. Cipla Ltd
7.6. Dr Reddys Laboratories Ltd
7.7. F Hoffmann-La Roche Ltd
7.8. GlaxoSmithKline plc
7.9. Intas Pharmaceuticals Ltd (Accord Healthcare)
7.10. Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc)
7.11. Mylan Nv
7.12. Novartis AG
7.13. Pfizer Inc
7.14. Sanofi
7.15. Veloxis Pharmaceuticals Inc

8. Methodology & Scope
8.1. Research Scope
8.2. Sources of Data
8.3. Research Methodology

List of Tables
Table 1: Global Immunosuppressant Drugs Market, by Geography, 2019-2028 (In $ Million)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: Side-Effects of Immunosuppressant Drugs
Table 5: Top 15 Positive Net Exports Countries and Negative Net Exports for Drugs & Medicines Countries
Table 6: Global Immunosuppressant Drugs Market, by Drug Class, 2019-2028 (In $ Million)
Table 7: Global Immunosuppressant Drugs Market, by Distribution Channel, 2019-2028 (In $ Million)
Table 8: Global Immunosuppressant Drugs Market, by End-User, 2019-2028 (In $ Million)
Table 9: Global Immunosuppressant Drugs Market, by Geography, 2019-2028 (In $ Million)
Table 10: North America Immunosuppressant Drugs Market, by Country, 2019-2028 (In $ Million)
Table 11: North America Immunosuppressant Drugs Market, by Drug Class, 2019-2028 (In $ Million)
Table 12: North America Immunosuppressant Drugs Market, by Distribution Channel, 2019-2028 (In $ Million)
Table 13: North America Immunosuppressant Drugs Market, by End-User, 2019-2028 (In $ Million)
Table 14: Europe Immunosuppressant Drugs Market, by Country, 2019-2028 (In $ Million)
Table 15: Europe Immunosuppressant Drugs Market, by Drug Class, 2019-2028 (In $ Million)
Table 16: Europe Immunosuppressant Drugs Market, by Distribution Channel, 2019-2028 (In $ Million)
Table 17: Europe Immunosuppressant Drugs Market, by End-User, 2019-2028 (In $ Million)
Table 18: Asia-Pacific Immunosuppressant Drugs Market, by Country, 2019-2028 (In $ Million)
Table 19: Asia-Pacific Immunosuppressant Drugs Market, by Drug Class, 2019-2028 (In $ Million)
Table 20: Asia-Pacific Immunosuppressant Drugs Market, by Distribution Channel, 2019-2028 (In $ Million)
Table 21: Asia-Pacific Immunosuppressant Drugs Market, by End-User, 2019-2028 (In $ Million)
Table 22: Latin America Immunosuppressant Drugs Market, by Country, 2019-2028 (In $ Million)
Table 23: Latin America Immunosuppressant Drugs Market, by Drug Class, 2019-2028 (In $ Million)
Table 24: Latin America Immunosuppressant Drugs Market, by Distribution Channel, 2019-2028 (In $ Million)
Table 25: Latin America Immunosuppressant Drugs Market, by End-User, 2019-2028 (In $ Million)
Table 26: Middle East and Africa Immunosuppressant Drugs Market, by Country, 2019-2028 (In $ Million)
Table 27: Middle East and Africa Immunosuppressant Drugs Market, by Drug Class, 2019-2028 (In $ Million)
Table 28: Middle East and Africa Immunosuppressant Drugs Market, by Distribution Channel, 2019-2028 (In $ Million)
Table 29: Middle East and Africa Immunosuppressant Drugs Market, by End-User, 2019-2028 (In $ Million)

List of Figures
Figure 1: Evolution & Transition of Immunosuppressant Drugs
Figure 2: Porter's Five Force Analysis
Figure 3: Global Immunosuppressant Drugs Market, by Corticosteroids, 2019-2028 (In $ Million)
Figure 4: Global Immunosuppressant Drugs Market, by Monoclonal Antibodies, 2019-2028 (In $ Million)
Figure 5: Global Immunosuppressant Drugs Market, by Calcineurin Inhibitors, 2019-2028 (In $ Million)
Figure 6: Global Immunosuppressant Drugs Market, by Mtor Inhibitors, 2019-2028 (In $ Million)
Figure 7: Global Immunosuppressant Drugs Market, by Others, 2019-2028 (In $ Million)
Figure 8: Global Immunosuppressant Drugs Market, by Hospital Pharmacies, 2019-2028 (In $ Million)
Figure 9: Global Immunosuppressant Drugs Market, by Retail Pharmacies, 2019-2028 (In $ Million)
Figure 10: Global Immunosuppressant Drugs Market, by Online Pharmacies, 2019-2028 (In $ Million)
Figure 11: Global Immunosuppressant Drugs Market, by Organ Transplantation, 2019-2028 (In $ Million)
Figure 12: Global Immunosuppressant Drugs Market, by Autoimmune Disorders, 2019-2028 (In $ Million)
Figure 13: Global Immunosuppressant Drugs Market, by Others, 2019-2028 (In $ Million)
Figure 14: Global Immunosuppressant Drugs Market, Regional Outlook, 2019 & 2028 (In %)
Figure 15: United States Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 16: Canada Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 17: United Kingdom Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 18: Germany Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 19: France Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 20: Spain Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 21: Italy Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 22: Russia Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 23: Rest of Europe Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 24: China Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 25: Japan Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 26: India Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 27: South Korea Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 28: Asean Countries Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 29: Australia & New Zealand Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 30: Rest of Asia-Pacific Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 31: Brazil Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 32: Mexico Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 33: Rest of Latin America Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 34: United Arab Emirates Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 35: Turkey Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 36: Saudi Arabia Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 37: South Africa Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 38: Rest of Middle East & Africa Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbvie Inc
  • Allergan (Acquired by Abbvie Inc)
  • Astellas Pharma Inc
  • Bristol-Myers Squibb Company
  • Cipla Ltd
  • Dr Reddys Laboratories Ltd
  • F Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Intas Pharmaceuticals Ltd (Accord Healthcare)
  • Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc)
  • Mylan Nv
  • Novartis AG
  • Pfizer Inc
  • Sanofi
  • Veloxis Pharmaceuticals Inc
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll